Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen, Cytori Therapeutics

Invitrogen this week announced the availability of the Stempro human adipose- derived stem cell kit.
The kit consists of adipose-derived stem cells from human lipoaspirate tissue obtained under license from Cytori Therapeutics, which are passaged once before they are cryopreserved from primary cultures.
The kit also includes MesenPRO RS medium, a reduced serum (2 percent) medium optimized for the expansion of human mesenchymal stem cells.

Compared with bone marrow-derived mesenchymal stem cells, ADSCs have very similar phenotypic and functional characteristics and have an equal potential to differentiate into cells and tissues of mesodermal origin such as bone, cartilage, and adipocytes, the company said.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.